亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Novel Formulation of Dehydrated Lipid Vesicles for Controlled Release of Active Pharmaceutical Ingredient via Inhalation (用於控制釋放藥物活性成分的新型脂質體氣霧劑)

總結: A new formulation of dehydrated lipid vesicles employs a vesicle preserver and permits the control of release and delivery of active pharmaceutical ingredients into the respiratory system for treatment in particular of asthma.

技術優勢: Allow prolonged therapeutic period for one administration, Increased stability with reduced dose, Reduce systemic side effects, Reduce toxicity

詳細技術說明: A new formulation of dehydrated lipid vesicles employs a vesicle preserver and permits the control of release and delivery of active pharmaceutical ingredients into the respiratory system for treatment in particular of asthma. The typical formulation provides controlled release of the active pharmaceutical ingredient from 0% to 100% from 0 to 72 hours after inhalation, changes the systemic administration to topical administration, allows prolonged therapeutic period for one administration, increased stability, with reduced dose, reduced systemic side effects, reduced toxicity

附加資料: Patent Number: US20090047336A1
Application Number: US2007840537A
Inventor: Yang, Zhijun | Huang, Wenhua | Wong, Chi Sun | Zhao, Zhongzhen
Priority Date: 17 Aug 2007
Priority Number: US20090047336A1
Application Date: 17 Aug 2007
Publication Date: 19 Feb 2009
IPC Current: A61K0031137 | A61K0009127 | A61K000914 | A61K004706 | A61P001100 | A61P001106
US Class: 424450 | 424489 | 514653 | 514772
Assignee Applicant: Hong Kong Baptist University
Title: NOVEL FORMULATION OF DEHYDRATED LIPID VESICLES FOR CONTROLLED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT VIA INHALATION
Usefulness: NOVEL FORMULATION OF DEHYDRATED LIPID VESICLES FOR CONTROLLED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT VIA INHALATION
Summary: The pharmaceutical lipid composition is useful for treating respiratory system diseases, preferably asthma by inhalation into a respiratory system (claimed).
Novelty: Composition useful for treating respiratory system diseases, preferably asthma by inhalation into respiratory system, comprises dehydrated lipid vesicles of vesicle preserver, lipid component and active ingredient e.g. albuterol

欲了解更多信息，請點擊這裡